Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Omicron poses very high global risk, world must prepare -WHO

Published 29/11/2021, 08:14
Updated 29/11/2021, 12:30
© Reuters. A vial and a syringe are seen in front of a displayed stock graph and words "Omicron SARS-CoV-2" in this illustration taken, November 27, 2021. REUTERS/Dado Ruvic/Illustration/file photo

By Stephanie Nebehay

GENEVA (Reuters) -The heavily mutated Omicron coronavirus variant is likely to spread internationally and poses a very high risk of infection surges that could have "severe consequences" in some places, the World Health Organization (WHO) said on Monday.

No Omicron-linked deaths had yet been reported, though further research was needed to assess its potential to resist vaccines and immunity induced by previous infections, it added.

Anticipating increased case numbers as the variant, first reported last week, spreads, the U.N. agency urged its 194 member states to accelerate vaccination of high-priority groups.

"Omicron has an unprecedented number of spike mutations, some of which are concerning for their potential impact on the trajectory of the pandemic," the WHO said.

"The overall global risk ...is assessed as very high."

Tedros Adhanom Ghebreyesus, WHO director-general, said Omicron's emergence showed how "perilous and precarious" the situation was.

"Omicron demonstrates just why the world needs a new accord on pandemics," he told the start of an assembly of health ministers expected to launch negotiations on such an agreement.

"Our current system disincentivizes countries from alerting others to threats that will inevitably land on their shores."

The new global deal, expected by May 2024, would cover issues such as sharing of data and genome sequences of emerging viruses, and of any potential vaccines derived from research.

Scientist Richard Hatchett, CEO of the Coalition for Epidemic Preparedness Innovations (CEPI), a foundation that funds vaccine development, said Omicron's emergence had fulfilled predictions that transmission of the virus in areas with low vaccination rates would speed its evolution. 

"The inequity that has characterized the global response has now come home to roost," he told the talks, noting that Botswana and South Africa had fully vaccinated less than a quarter of their populations.

'OVERWHELMING DEMANDS'

Omicron was first reported on Nov. 24 from South Africa, where infections have risen steeply.

It has since spread to more than a dozen countries, many of which have imposed travel restrictions to try to seal themselves off. Japan on Monday joined Israel in saying it would close its borders completely to foreigners.

The WHO reiterated that, pending further advice, countries should use a "risk-based approach to adjust international travel measures", while acknowledging that a rise in coronavirus cases might lead to higher morbidity and mortality rates.

"The impact on vulnerable populations would be substantial, particularly in countries with low vaccination coverage," it added.

© Reuters. A vial and a syringe are seen in front of a displayed stock graph and words

In vaccinated persons, meanwhile, "COVID-19 cases and infections are expected ... albeit in a small and predictable proportion".

Overall, there were "considerable uncertainties in the magnitude of immune escape potential of Omicron", and more data was expected in coming weeks.

Latest comments

why do they push vaccines at the same time as saying that the new variant evades vaccines?
I think you make us leave like scare world please stop nonsense
viruses mutate all the time.Get on with life instead of hyping up a mild variant as a rampaging risk
it seems that WHO officials are having very heavy short positions.
If symptoms are mild, its best to let this variant spread. Let our natural immune system do its job. Scientists and doctors can advise everyone how to get our immune systems into best condition.
Markets can continue to fall as panic sets in regardless how virulent omicron is
This could be the end of the pandemic. Omicron is mild and could even be a 'natural vaccine', speedily infecting billions with mild symptoms and conferring immunity to more severe strains like Delta and Beta.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.